The coronavirus vaccine

After Israel roll out, EU drug regulator doubts need for 4th booster dose

EMA official says no data available to support need for jab to fight Omicron, recommends spacing vaccines, claims short intervals cannot represent a sustainable long-term strategy

Ynet, Reuters |
Updated: 01.12.22, 08:34
The European Union's drug regulator on Tuesday expressed doubts about the need for a fourth booster dose of COVID-19 vaccine and said there is currently no data to support this approach as it seeks more data on the fast-spreading Omicron variant.
  • Follow Ynetnews on Facebook and Twitter

  • "While use of additional boosters can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long-term strategy," the European Medicines Agency's Head of Vaccines Strategy, Marco Cavaleri, told a media briefing.
    2 צפייה בגלריה
    חיסון קורונה בנתניה
    חיסון קורונה בנתניה
    The coronavirus vaccine
    (Photo: AFP)
    Israel launched its drive to administer the fourth dose of the Pfizer vaccine to its over 60 population and those at high risk from COVID-19, last week.
    The EMA official raised concerns that a strategy of giving boosters every four months hypothetically poses the risk of overloading people's immune systems and leading to fatigue in the population.
    Cavaleri also said more data on the impact of the new variant on vaccines and a better understanding of the evolution of the current wave were needed to decide whether an Omicron-specific vaccine was needed.
    2 צפייה בגלריה
    חיסון קורונה בתל אביב
    חיסון קורונה בתל אביב
    The 4th dose of the coronavirus vaccine administered to an elderly person in Tel Aviv last week
    (Photo: AFP)
    "It is important that there is a good discussion around the choice of the composition of the vaccine to make sure that we have a strategy that is not just reactive ... and try to come up with an approach that will be suitable in order to prevent a future variant," he said.
    The EMA said it was currently in conversation with vaccine developers in case there is a need for an updated vaccine but added that any such change would need to be coordinated globally.
    First published: 08:09, 01.12.22
    Talkbacks for this article 0